Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (2127)	10/8/1997 5:52:00 AM
From: Henry Niman	of 6136

<<I used to own Ligand. Henry Ninman has always stated he knows nothing about business or investing, and does not give investment advice. His claim to fame is his expertise as a scientist, not as an investor. Ligand investors have been waiting quite awhile for this diabetes deal which is coming "any day" now.>> margie, LGND investors are still waiting for the diabetes deal, but CEO Robinson was conspicuously abstent for the LGND UBS presentation yesterday and was working on "increasing shareholder value". Investors must have liked what they heard. LGND set a 52-week high ($18) and a 52-week closing high (17 1/4) on volume of almost 3/4 million shares yesterday. Maybe they expect the deal "any day" now, or just rose in sympathy with their San Diego Biotech neighbor, AGPH.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next